Extracellular Volume Fraction Based on Cardiac Magnetic Resonance T1 Mapping: An Effective Way to Evaluate Cardiac Injury Caused by Cardiac Amyloidosis in Patients with Multiple Myeloma

Figure 2

The comparison of biochemical parameters between patients with or without CA. (a) β2-microglobulin (β2-MG) (CA, ; non-CA, ). (b) Lactate dehydrogenase 1 (LDH1) (CA, ; non-CA, ). (c) High-Sensitivity Troponin I (hs-TNI) (CA, ; non-CA, ). (d) Pro-brain natural peptide (pro-BNP) (CA, ; non-CA, ). (e) Left ventricular ejection fraction (LVEF) (CA, ; non-CA, ). (f) Myocardial mass (CF/BAS) (CA, ; non-CA, ). (g) Basal ECV (CA, ; non-CA, ). (h) Mid ECV (CA, ; non-CA, ). (i) Apical ECV (CA, ; non-CA, ).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)